Japan Medical Dynamic Marketing, INC. (TYO:7600)
Japan · Delayed Price · Currency is JPY 653.00
-1.00 (-0.15%)
Sep 15, 2026, 3:30 PM JST
TYO:7600 Ratios and Metrics
Market cap in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Total Valuation
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 14, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 17,209 | 14,152 | 15,011 | 19,356 | 27,379 | 43,217 | |
Market Cap Growth | 31.48% | -5.72% | -22.45% | -29.30% | -36.65% | -27.68% |
Enterprise Value | 21,300 | 17,224 | 15,488 | 19,343 | 26,764 | 43,498 |
Last Close Price | 653.00 | 537.00 | 553.26 | 696.85 | 968.28 | 1504.19 |
Price Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 14, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | - | 53.81 | - | 15.23 | 19.24 | 20.24 |
Forward PE | - | 30.30 | 10.91 | 11.45 | 16.87 | 20.33 |
PS Ratio | 0.74 | 0.59 | 0.60 | 0.84 | 1.29 | 2.25 |
PB Ratio | 0.69 | 0.56 | 0.61 | 0.76 | 1.18 | 2.01 |
P/TBV Ratio | 0.71 | 0.57 | 0.62 | 0.77 | 1.20 | 2.05 |
P/FCF Ratio | - | - | - | 60.30 | 28.40 | 27.49 |
P/OCF Ratio | 83.95 | 69.03 | 14.35 | 9.20 | 12.53 | 13.89 |
EV Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 14, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
EV/Sales Ratio | 0.91 | 0.72 | 0.62 | 0.84 | 1.26 | 2.27 |
EV/EBITDA Ratio | 14.81 | 7.87 | 4.80 | 5.79 | 7.49 | 10.66 |
EV/EBIT Ratio | - | 29.96 | 9.95 | 11.07 | 13.22 | 16.34 |
EV/FCF Ratio | - | - | - | 60.26 | 27.76 | 27.67 |
Financial Efficiency
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 14, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Debt / Equity Ratio | 0.27 | 0.23 | 0.13 | 0.06 | 0.08 | 0.09 |
Debt / EBITDA Ratio | 4.43 | 2.68 | 1.02 | 0.45 | 0.52 | 0.45 |
Debt / FCF Ratio | - | - | - | 4.65 | 1.94 | 1.18 |
Net Debt / Equity Ratio | 0.16 | 0.11 | 0.00 | -0.03 | -0.04 | -0.04 |
Net Debt / EBITDA Ratio | 2.72 | 1.26 | 0.03 | -0.25 | -0.26 | -0.18 |
Net Debt / FCF Ratio | - | -1.57 | -0.20 | -2.58 | -0.97 | -0.47 |
Asset Turnover | 0.69 | 0.69 | 0.77 | 0.76 | 0.75 | 0.73 |
Inventory Turnover | 0.64 | 0.65 | 0.70 | 0.68 | 0.67 | 0.64 |
Quick Ratio | 0.88 | 1.08 | 1.28 | 2.04 | 2.23 | 2.69 |
Current Ratio | 2.99 | 3.23 | 3.29 | 5.36 | 5.51 | 6.23 |
Return on Equity (ROE) | -0.89% | 1.09% | -1.86% | 5.33% | 6.41% | 10.65% |
Return on Assets (ROA) | -0.19% | 1.04% | 2.99% | 3.58% | 4.46% | 6.33% |
Return on Invested Capital (ROIC) | -0.36% | 1.21% | 6.27% | 5.91% | 7.62% | 10.35% |
Return on Capital Employed (ROCE) | -0.40% | 2.10% | 5.90% | 6.40% | 7.80% | 10.90% |
Yields
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 14, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Earnings Yield | -1.28% | 1.86% | -3.07% | 6.57% | 5.20% | 4.94% |
FCF Yield | -10.20% | -12.41% | -3.36% | 1.66% | 3.52% | 3.64% |
Dividend Yield | 2.60% | 3.17% | 2.71% | 2.01% | 1.34% | 0.80% |
Payout Ratio | - | 150.57% | - | 26.99% | 22.28% | 13.58% |
Buyback Yield / Dilution | -0.06% | -0.05% | -0.05% | 0.11% | 0.12% | 0.00% |
Total Shareholder Return | 2.54% | 3.12% | 2.67% | 2.12% | 1.46% | 0.80% |